Search research articles
Contact Us
Filters
Showing results (321-330 of 338) with videos related to
Page
of 34
Sort By:
JCI Insight
|
March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Meagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Cancer Medicine
|
October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen
Alaa M Ali, Daniel Weisel, Feng Gao, et al.
Haematologica
|
March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
Francesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Leukemia & Lymphoma
|
December 15, 2022
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612
Sarit Assouline, Laura C Michaelis, Megan Othus, et al.
Blood Advances
|
June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML
Andrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
Blood
|
January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
Eric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Blood
|
November 19, 2021
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
Melissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, et al.
Leukemia
|
October 15, 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy
G L Uy, E J Duncavage, G S Chang, et al.
Blood Cancer Discovery
|
June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression
Andrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Nature Reviews. Microbiology
|
November 4, 2011
Tackling antibiotic resistance
Karen Bush, Patrice Courvalin, Gautam Dantas, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 338) with videos related to
Sort By:
Page
of 34
JCI Insight
|
March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Meagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Cancer Medicine
|
October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen
Alaa M Ali, Daniel Weisel, Feng Gao, et al.
Haematologica
|
March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
Francesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Leukemia & Lymphoma
|
December 15, 2022
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612
Sarit Assouline, Laura C Michaelis, Megan Othus, et al.
Blood Advances
|
June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML
Andrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
Blood
|
January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
Eric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Blood
|
November 19, 2021
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
Melissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, et al.
Leukemia
|
October 15, 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy
G L Uy, E J Duncavage, G S Chang, et al.
Blood Cancer Discovery
|
June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression
Andrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Nature Reviews. Microbiology
|
November 4, 2011
Tackling antibiotic resistance
Karen Bush, Patrice Courvalin, Gautam Dantas, et al.
Page
of 34